‘Door-to-furosemide’ timing: early treatment of heart failure-Reference-Cited by-同舟云学术

‘Door-to-furosemide’ timing: early treatment of heart failure

Published:2019-03-01 Issue:Supplement_B Volume:21 Page:B69-B70
ISSN:1520-765X
Container-title:European Heart Journal Supplements
language:en
Short-container-title:

Author:

Piazza Vito¹

Affiliation:

1. Cardiology Unit, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartjsupp/article-pdf/21/Supplement_B/B69/28243296/suz001.pdf

Reference5 articles.

1. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure;Maisel;J Am Coll Cardiol,2008

2. Early initiation of intravenous vasoactive therapy improves heart failure outcomes: an analysis from the ADHERE registry database;Peacock;Ann Emerg Med,2003

3. Early vasoactive drugs improve heart failure outcomes;Peacock;Congest Heart Fail,2009

4. Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure;Matsue;J Am Coll Cardiol,2017

5. Door-to-furosemide therapy in the ED;Jannuzzi;J Am Coll Cardiol,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Relationship Between Accurate Triage and Core Measures Compliance for Acute Myocardial Infarction and Heart Failure in older Adults Presenting to the Emergency Department;Journal of Nursing Care Quality;2023-10-02

2. ‘Time is prognosis’ in heart failure: time‐to‐treatment initiation as a modifiable risk factor;ESC Heart Failure;2021-10-16